Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data

por Swart, Nicholas, Maroni, Roberta, Muldrew, Beth, Sasieni, Peter, Fitzgerald, Rebecca C., Morris, Stephen
Publicado 2021

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

por Fitzgerald, Rebecca C, di Pietro, Massimiliano, O'Donovan, Maria, Maroni, Roberta, Muldrew, Beth, Debiram-Beecham, Irene, Gehrung, Marcel, Offman, Judith, Tripathi, Monika, Smith, Samuel G, Aigret, Benoit, Walter, Fiona M, Rubin, Greg, Sasieni, Peter
Publicado 2020

Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal...

por Offman, Judith, Muldrew, Beth, O’Donovan, Maria, Debiram-Beecham, Irene, Pesola, Francesca, Kaimi, Irene, Smith, Samuel G., Wilson, Ashley, Khan, Zohrah, Lao-Sirieix, Pierre, Aigret, Benoit, Walter, Fiona M., Rubin, Greg, Morris, Steve, Jackson, Christopher, Sasieni, Peter, Fitzgerald, Rebecca C.
Publicado 2018